Eugene Schneider
Chief Tech/Sci/R&D Officer at IONIS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 31/03/2024
Profile
Presently, Eugene Schneider occupies the position of Chief Clinical Development Officer & Executive VP at Ionis Pharmaceuticals, Inc. Dr. Schneider is also Medical Director & VP-Behavioral Health at Excellus BlueCross BlueShield. In the past Dr. Schneider was Senior Medical Director at Biovail Technologies Ltd. and Senior Medical Director at Synageva BioPharma Corp. He received a doctorate from the University of Medicine & Dentistry of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/02/2024 | 49,812 ( 0.03% ) | 2 M $ | 31/03/2024 |
Eugene Schneider active positions
| Companies | Position | Start |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Excellus Health Plan, Inc.
 Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Former positions of Eugene Schneider
| Companies | Position | End |
|---|---|---|
| Biovail Technologies Ltd. | Chief Tech/Sci/R&D Officer | - |
| SYNAGEVA BIOPHARMA CORP | Chief Tech/Sci/R&D Officer | - |
Training of Eugene Schneider
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Excellus Health Plan, Inc.
Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Health Services |
| Biovail Technologies Ltd. | |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Eugene Schneider
